Microtransponder-based multiplex assay for genotyping cystic fibrosis

Clinical Chemistry

Volumn 53, Issue 7, 2007, Pages 1372-1376

  Lin, Xin ^a   Flint, James A ^a   Azaro, Marco ^a   Coradetti, Thomas ^a   Kopacka, Wesley M ^a   Streck, Deanna L ^b   Wang, Zhuying ^a   Dermody, James ^b   Mandecki, Wlodek ^a  

^a PharmaSeq Inc   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT;

ARTICLE; CFTR GENE; CYSTIC FIBROSIS; FLUORESCENCE; GENE; GENE MUTATION; GENOTYPE; HUMAN; MICROCHIP ANALYSIS; POLYMERASE CHAIN REACTION; RADIOFREQUENCY;

AFRICAN AMERICANS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ELECTRONICS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOTYPE; HISPANIC AMERICANS; HUMANS; MICROCHIP ANALYTICAL PROCEDURES; MUTATION; POLYMERASE CHAIN REACTION;

EID: 34347403219     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.081810     Document Type: Article

References (19)

1. Palomaki GE, FitzSimmons SC, Haddow JE. Clinical sensitivity of prenatal screening for cystic fibrosis via CFTR carrier testing in a United States panethnic population. Genet Med 2004;6:405-14.
2. American College of Obstetrics and American College of Medical Genetics. Preconception and prenatal carrier screening for cystic fibrosis: clinical and laboratory guidelines. Washington, DC: American College of Obstetrics and Gynecology, 2001:32pp.
3. Mandecki W, Ardelt B, Coradetti T, Davidowitz H, Flint J, Huang Z, et al. Microtransponders, the miniature RFID electronic chips, as platforms for cell growth in cytotoxicity assays. Cytometry A 2006;69:1097-105.
4. Ye F, Li MS, Taylor JD, Nguyen Q, Colton HM, Casey WM, et al. Fluorescent microsphere-based readout technology for multiplexed human single nucleotide polymorphism analysis and bacterial identification. Hum Mutat 2001; 17:305-16.
5. Taylor JD, Briley D, Nguyen Q, Long K, Lannone MA, Li MS, et al. Flow cytometric platform for high-throughput single nucleotide polymorphism analysis. BioTechniques 2001;30:661-9.
6. Tm Bioscience. http://www.tmbioscience.com/tm100universalarray.php (accessed February 2007).
7. Wang DG, Fan JB, Siao CJ, Berno A, Young P, Sapolsky R, et al. Large-scale identification, mapping and genotyping of single nucleotide polymorphisms in the human genome. Science 1988;280:1077-82.
8. Gerry NP, Witowski NE, Day J, Hammer RP, Barany G, Barany F. Universal DNA microarray method for multiplex detection of low abundance point mutations. J Mol Biol 1999;292:251-62.
9. Azaro MA, Lin X, Mandecki W. SimuPlex: primer design software for multiplex PCR. Poster presentation, NIH Small Business Innovation Research Conference, July 2005, Bethesda, MD.
10. SantaLucia JJ, Hicks D. The thermodynamics of DNA structural motifs. Annu Rev Biophys Biomol Struct 2004;33:415-40.
11. The Santa Lucia Lab. http://ozone3.chem.wayne.edu (accessed February 2007).
12. Strom CM, Janeczko R, Quan F, Wang SB, Buller A, McGinniss M, et al. Technical validation of Tm Biosciences Luminex-based multiplex assay for detecting the American College of Medical Genetics recommended cystic fibrosis mutation panel. J Mol Diagn 2006;8:371-5.
13. Strom CM, Clark DD, Hantash FM, Rea L, Anderson B, Maul D, et al. Direct visualization of cystic fibrosis transmembrane regulator mutations in the clinical laboratory setting. Clin Chem 2004;50:836-45.
14. CDC web site: http://www.cdc.gov/genomics/gtesting/ACCE/FBR/CF/ CFCliVal19c.htm (accessed February 2007).
15. Palomaki GE, Haddow JE, Bradley LA, FitzSimmons SC. Updated assessment of cystic fibrosis mutation frequencies in non-Hispanic Caucasians. Genet Med 2002;4:90-4.
16. Kazazian HH. Population variation of common cystic fibrosis mutations. Hum Mutat 1994;4:167-77.
17. Tomaiuolo R, Spina M, Castaldo G. Molecular diagnosis of cystic fibrosis: comparison of four analytical procedures. Clin Chem Lab Med 2003;41:26-32.
18. Heim RA, Sugarman EA, Allitto BA. Improved detection of cystic fibrosis mutations in the heterogeneous U.S. population using an expanded, pan-ethnic mutation panel. Genet Med 2001;3:168-76.
19. Bobadilla JL, Macek M Jr, Fine JP, Farrell PM. Cystic fibrosis: a worldwide analysis of CFTR mutations: correlation with incidence data and application to screening. Hum Mutat 2002;19:575-606.